Cited by 2,780interferon and immune responsesImmune Response and InflammationCytokine Signaling Pathways and Interactions

The DOI matches its Crossref record; 238 of the 238 references it cites were found in a registry or an index.

Type I interferons in infectious disease

Open access

McNab, Finlay, Mayer-Barber, Katrin, Sher, Alan, Wack, Andreas, O'Garra, Anne·2015·Nature Reviews Immunology

DOI 10.1038/nri3787PMC PMC7162685

Open this paper in CoChat — free account Open PDF

Abstract

Type I interferons (IFNs) have diverse effects on innate and adaptive immune cells during infection with viruses, bacteria, parasites and fungi, directly and/or indirectly through the induction of other mediators. Type I IFNs are important for host defence against viruses. However, recently, they have been shown to cause immunopathology in some acute viral infections, such as influenza virus infection. Conversely, they can lead to immunosuppression during chronic viral infections, such as lymphocytic choriomeningitis virus infection. During bacterial infections, low levels of type I IFNs may be required at an early stage, to initiate cell-mediated immune responses. High concentrations of type I IFNs may block B cell responses or lead to the production of immunosuppressive molecules, and such concentrations also reduce the responsiveness of macrophages to activation by IFNγ, as has been shown for infections with Listeria monocytogenes and Mycobacterium tuberculosis. Recent studies in experimental models of tuberculosis have demonstrated that prostaglandin E2 and interleukin-1 inhibit type I IFN expression and its downstream effects, demonstrating that a cross-regulatory network of cytokines operates during infectious diseases to provide protection with minimum damage to the host.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nri3787

Cites

238 of 238 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,871
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J. V., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,533
Regulation of type I interferon responses
Ivashkiv, L. B., & Donlin, L. T. (2013) · Nature reviews. Immunology · doi:10.1038/nri3581 · Cited by 3,442
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., Ó’hUigín, C., Kidd, J. R., Kídd, K. K., Khakoo, S. I., Alexander, G., et al. (2009) · Nature · doi:10.1038/nature08463 · Cited by 2,147
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Tanaka, Y., Nishida, N., Sugiyama, M., Kurosaki, M., Matsuura, K., Sakamoto, N., Nakagawa, M., Korenaga, M., Hino, K., Hige, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.449 · Cited by 2,141
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
Self-citation
Interferons, interferon‐like cytokines, and their receptors
Pestka, S., Krause, C. D., & Walter, M. R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00204.x · Cited by 1,845
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Study, F. T. H. C., Suppiah, V., Moldovan, M. V., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M. L., Bassendine, M. F., Spengler, U., Dore, G. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.447 · Cited by 1,829

Flagged first, then by citations

Show all 238 references

Sorted by citations

Items 501–600 of 1,004

Current knowledge of immunomodulation strategies for chronic skin wound repair
Heydari, P., Kharaziha, M., Varshosaz, J., & Javanmard, S. H. (2021) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.34921 · Cited by 49
Immunosuppressive Mechanisms in Brucellosis in Light of Chronic Bacterial Diseases
Pellegrini, J. M., Gorvel, J., & Mémet, S. (2022) · Microorganisms · doi:10.3390/microorganisms10071260 · Cited by 49
Molecular, ecological, and behavioral drivers of the bat-virus relationship
Gonzalez, V., & Banerjee, A. (2022) · iScience · doi:10.1016/j.isci.2022.104779 · Cited by 56
Role of Interferons in Mycobacterium tuberculosis Infection
Shanmuganathan, G., Orujyan, D., Narinyan, W., Poladian, N., Dhama, S., Parthasarathy, A., Ha, A., Tran, D., Velpuri, P., Nguyen, K., et al. (2022) · Clinics and Practice · doi:10.3390/clinpract12050082 · Cited by 53
Physiological functions of ULK1/2
Pareek, G., & Kundu, M. (2024) · Journal of Molecular Biology · doi:10.1016/j.jmb.2024.168472 · Cited by 55
Type I interferons induce an epigenetically distinct memory B cell subset in chronic viral infection
Cooper, L., Xu, H. M., Polmear, J., Kealy, L. C., Szeto, C. W., Pang, E. S., Gupta, M., Kirn, A., Taylor, J. J., Jackson, K., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.016 · Cited by 54
Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection
Kijak, G. H., Sanders‐Buell, E., Chenine, A.-L., Eller, M. A., Goonetilleke, N. P., Thomas, R., Leviyang, S., Harbolick, E. A., Bose, M., Pham, P. T., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006510 · Cited by 49
Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome
Scagnolari, C., & Antonelli, G. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.03.003 · Cited by 49
RNA sensor LGP2 inhibits TRAF ubiquitin ligase to negatively regulate innate immune signaling
Parisien, J.-P., Lenoir, J. J., Mandhana, R., Rodriguez, K. R., Qian, K., Bruns, A. M., & Horvath, C. M. (2018) · EMBO Reports · doi:10.15252/embr.201745176 · Cited by 52
Decoding the dynamics of multilayered stochastic antiviral IFN-I responses
Eyndhoven, L. C. V., Singh, A., & Tel, J. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.07.004 · Cited by 49
Interferon β-Mediated Protective Functions of Microglia in Central Nervous System Autoimmunity
Scheu, S., Ali, S., Mann‐Nüttel, R., Richter, L., Arolt, V., Dannlowski, U., Kuhlmann, T., Klotz, L., & Alferink, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010190 · Cited by 49
OAS1/RNase L executes RIG-I ligand–dependent tumor cell apoptosis
Boehmer, D. F. R., Formisano, S., Mann, C. C. D. O., Müller, S. A., Kluge, M., Metzger, P., Rohlfs, M., Hörth, C., Kocheise, L., Lichtenthaler, S. F., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abe2550 · Cited by 48
Interferon gamma immunotherapy in five critically ill COVID-19 patients with impaired cellular immunity: A case series
van Laarhoven, A., Kurver, L., Overheul, G. J., Kooistra, E. J., Abdo, W. F., van Crevel, R., Duivenvoorden, R., Kox, M., ten Oever, J., Schouten, J. A., et al. (2021) · Med · doi:10.1016/j.medj.2021.09.003 · Cited by 51
Fatty acid metabolism in T-cell function and differentiation
Endo, Y., Kanno, T., & Nakajima, T. (2022) · International Immunology · doi:10.1093/intimm/dxac025 · Cited by 52
Microbiota-derived short chain fatty acids: Their role and mechanisms in viral infections
Feng, C., Jin, C., Liu, K., & Yang, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114414 · Cited by 51
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
Rodríguez‐Carrio, J., Burska, A. N., Conaghan, P. G., Dik, W. A., Biesen, R., Eloranta, M., Cavalli, G., Visser, M., Boumpas, D. T., Bertsias, G. K., et al. (2023) · RMD Open · doi:10.1136/rmdopen-2022-002864 · Cited by 48
Evaluation of the Xpert MTB Host Response assay for the triage of patients with presumed pulmonary tuberculosis: a prospective diagnostic accuracy study in Viet Nam, India, the Philippines, Uganda, and South Africa
Gupta‐Wright, A., Ha, H., Abdulgadar, S., Crowder, R. R., Emmanuel, J., Mukwatamundu, J., Marcelo, D., Phillips, P. P. J., Christopher, D. J., Nhung, N. V., et al. (2024) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00541-7 · Cited by 48
Gut microbiome-metabolome interactions predict host condition
Shtossel, O., Koren, O., Shai, I., Rinott, E., & Louzoun, Y. (2024) · Microbiome · doi:10.1186/s40168-023-01737-1 · Cited by 49
Injectable supramolecular hydrogel co-loading abemaciclib/NLG919 for neoadjuvant immunotherapy of triple-negative breast cancer
Zhu, B., Cai, Y., Zhou, L., Zhao, L., Chen, J., Shan, X., Sun, X., You, Q., Gong, X., Zhang, W., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-55904-z · Cited by 48
Cytokines and persistent viral infections
Beltra, J., & Decaluwe, H. (2016) · Cytokine · doi:10.1016/j.cyto.2016.02.006 · Cited by 51
The Role of IFN-β during the Course of Sepsis Progression and Its Therapeutic Potential
Rackov, G., Shokri, R., Álvarez‐Mon, M., Martínez‐A, C., & Balomenos, D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00493 · Cited by 48
Ebola Virus Disease in Humans: Pathophysiology and Immunity
Muñoz‐Fontela, C., & McElroy, A. K. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_11 · Cited by 51
The lung-brain axis: A new frontier in host-microbe interactions
Azzoni, R., & Marsland, B. J. (2022) · Immunity · doi:10.1016/j.immuni.2022.03.015 · Cited by 47
MAVS deSUMOylation by SENP1 inhibits its aggregation and antagonizes IRF3 activation
Dai, T., Zhang, L., Ran, Y., Zhang, M., Yang, B., Lu, H., Lin, S., Zhang, L., & Zhou, F. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-00988-8 · Cited by 48
Interferon at the crossroads of SARS-CoV-2 infection and COVID-19 disease
Samuel, C. E. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104960 · Cited by 50
Targeted removal of macrophage-secreted interleukin-1 receptor antagonist protects against lethal Candida albicans sepsis
Gander-Bui, H. T. T., Schläfli, J., Baumgartner, J., Walthert, S., Genitsch, V., van Geest, G., Galván, J. A., Cardozo, C., Graham Martinez, C., Grans, M., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.06.023 · Cited by 47
Submicron-sized hydrogels incorporating cyclic dinucleotides for selective delivery and elevated cytokine release in macrophages
Lee, E. H., Jang, H.-E., Kang, Y. Y., Kim, J., Ahn, J., & Mok, H. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.10.025 · Cited by 48
The Ebola Interferon Inhibiting Domains Attenuate and Dysregulate Cell-Mediated Immune Responses
Lubaki, N. M., Younan, P. M., Santos, R. I., Meyer, M., Iampietro, M., Koup, R. A., & Bukreyev, A. A. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1006031 · Cited by 47
STING induces early IFN-β in the liver and constrains myeloid cell-mediated dissemination of murine cytomegalovirus
Tegtmeyer, P.-K., Spanier, J., Borst, K., Becker, J., Riedl, A., Hirche, C., Ghita, L., Skerra, J., Baumann, K., Lienenklaus, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10863-0 · Cited by 47
Coxsackievirus Type B3 Is a Potent Oncolytic Virus against KRAS-Mutant Lung Adenocarcinoma
Deng, H., Liu, H., de Silva, T., Xue, Y. C., Mohamud, Y., Ng, C. S., Qu, J., Zhang, J., Jia, W. W.-G., Lockwood, W. W., et al. (2019) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2019.07.003 · Cited by 48
Sustained IFN-I stimulation impairs MAIT cell responses to bacteria by inducing IL-10 during chronic HIV-1 infection
Tang, X., Zhang, S., Peng, Q., Ling, L., Shi, H., Liu, Y., Cheng, L., Xu, L., Cheng, L., Chakrabarti, L. A., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz0374 · Cited by 48
GPR183 Regulates Interferons, Autophagy, and Bacterial Growth During Mycobacterium tuberculosis Infection and Is Associated With TB Disease Severity
Bartlett, S., Gemiarto, A. T., Ngo, M. D., Sajiir, H., Hailu, S. G., Sinha, R., Foo, C. X., Kleynhans, L., Tshivhula, H., Webber, T., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.601534 · Cited by 47
Targeting nuclear acid-mediated immunity in cancer immune checkpoint inhibitor therapies
Chen, M., Hu, S., Li, Y., Jiang, T., Jin, H., & Feng, L. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00347-9 · Cited by 47
Single-cell atlas of the liver myeloid compartment before and after cure of chronic viral hepatitis
Cui, A., Li, B., Wallace, M. S., Gonye, A. L. K., Oetheimer, C., Patel, H., Tonnerre, P., Holmes, J. A., Lieb, D., Yao, B. S., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2023.02.040 · Cited by 46
Adaptive Immunity and the Risk of Autoreactivity in COVID-19
Moody, R., Wilson, K., Flanagan, K. L., Jaworowski, A., & Plebanski, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168965 · Cited by 49
The behavior and functions of embryonic microglia
Hattori, Y. (2021) · Anatomical Science International · doi:10.1007/s12565-021-00631-w · Cited by 53
Toll-Like Receptors (TLRs) in Health and Disease: An Overview
Kumar, V., & Barrett, J. E. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2021_568 · Cited by 46
Interferons and interferon-related pathways in heart disease
Tran, D. T., Batchu, S. N., & Advani, A. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1357343 · Cited by 46
Uncovering the impact of alcohol on internal organs and reproductive health: Exploring TLR4/NF‐kB and CYP2E1/ROS/Nrf2 pathways
Kong, E. Q. Z., Subramaniyan, V., & Lubau, N. S. A. (2024) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12436 · Cited by 48
Keap1 regulates inflammatory signaling in Mycobacterium avium -infected human macrophages
Awuh, J. A., Haug, M., Mildenberger, J., Marstad, A., Ngoc, C. P., Louet, C., Stenvik, J., Steigedal, M., Damås, J. K., Halaas, Ø., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423449112 · Cited by 46
High-Risk Human Papillomavirus Targets Crossroads in Immune Signaling
Tummers, B., & van der Burg, S. (2015) · Viruses · doi:10.3390/v7052485 · Cited by 51
Cyclic di-AMP in host–pathogen interactions
Devaux, L., Kaminski, P. A., Trieu‐Cuot, P., & Firon, A. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.11.007 · Cited by 49
Провоспалительные цитокины и заживление кожных ран у мышей
Nosenko, M. A., Амбарян, С. Г., & Друцкая, М. С. (2019) · Molecular Biology · doi:10.1134/s0026898419050136 · Cited by 46
Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?
Zanoni, I. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.08.004 · Cited by 49
Bacteria elicit a phage tolerance response subsequent to infection of their neighbors
Tzipilevich, E., Fiyaksel, O., Shraiteh, B., & Ben‐Yehuda, S. (2021) · The EMBO Journal · doi:10.15252/embj.2021109247 · Cited by 46
TRIM25 and ZAP target the Ebola virus ribonucleoprotein complex to mediate interferon-induced restriction
Galão, R. P., Wilson, H., Schierhorn, K. L., Debeljak, F., Bodmer, B. S., Goldhill, D. H., Hoenen, T., Wilson, S. J., Swanson, C. M., & Neil, S. J. D. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010530 · Cited by 48
Pattern of inflammatory immune response determines the clinical course and outcome of COVID-19: unbiased clustering analysis
Lee, E. E., Song, K., Hwang, W., Ham, S. Y., Jeong, H., Kim, J. H., Oh, H. S., Kang, Y. M., Lee, E. B., Kim, N. J., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-87668-z · Cited by 45
Whole blood transcriptional signatures associated with rapid antidepressant response to ketamine in patients with treatment resistant depression
Cathomas, F., Bevilacqua, L., Ramakrishnan, A., Kronman, H., Costi, S., Schneider, M., Chan, K. L., Li, L., Nestler, E. J., Shen, L., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-021-01712-0 · Cited by 47
Severe COVID-19 and long COVID are associated with high expression of STING, cGAS and IFN-α
Queiroz, M. A. F., Brito, W. R. D. S., Pereira, K. A. S., Pereira, L. M. S., Amoras, E. D. S. G., Lima, S. S., dos Santos, E. F., da Costa, F. P., de Sarges, K. M. L., Cantanhede, M. H. D., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-55696-0 · Cited by 45
Regulation of group 2 innate lymphoid cells
Duerr, C. U., & Fritz, J. H. (2016) · Cytokine · doi:10.1016/j.cyto.2016.01.018 · Cited by 46
Interferons reshape the 3D conformation and accessibility of macrophage chromatin
Platanitis, E., Gruener, S., Geetha, A. R. S. J., Boccuni, L., Vogt, A., Novatchkova, M., Sommer, A., Barozzi, I., Müller, M. M., & Decker, T. (2022) · iScience · doi:10.1016/j.isci.2022.103840 · Cited by 45
Oligoadenylate synthetase 1 displays dual antiviral mechanisms in driving translational shutdown and protecting interferon production
Harioudh, M. K., Pérez, J., Chong, Z., Nair, S., So, L., McCormick, K. D., Ghosh, A., Shao, L., Srivastava, R., Soveg, F. W., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.02.002 · Cited by 47
A Comprehensive Review on Porcine Reproductive and Respiratory Syndrome Virus with Emphasis on Immunity
Fiers, J., Cay, A. B., Maes, D. G. D., & Tignon, M. (2024) · Vaccines · doi:10.3390/vaccines12080942 · Cited by 46
The role of the AHR in host–pathogen interactions
Barreira‐Silva, P., Lian, Y., Kaufmann, S. H. E., & Moura‐Alves, P. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01088-4 · Cited by 44
Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancer
Link, J. M., Eng, J. R., Pelz, C., Hawthorne, K., Worth, P. J., Sivagnanam, S., Keith, D., Owen, S., Langer, E. M., Grossblatt-Wait, A., et al. (2025) · Nature Cancer · doi:10.1038/s43018-024-00881-3 · Cited by 44
Modulators of innate immunity as novel therapeutics for treatment of chronic hepatitis B
Suslov, A., Wieland, S. F., & Menne, S. (2018) · Current Opinion in Virology · doi:10.1016/j.coviro.2018.01.008 · Cited by 45
Type I Interferons, Autophagy and Host Metabolism in Leprosy
de Toledo-Pinto, T. G., Batista-Silva, L. R., Medeiros, R. C. A., Lara, F. A., & Moraes, M. O. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00806 · Cited by 44
Innate immunity limits protective adaptive immune responses against pre-erythrocytic malaria parasites
Minkah, N. K., Wilder, B. K., Sheikh, A. A., Martinson, T., Wegmair, L., Vaughan, A. M., & Kappe, S. H. I. (2019) · Nature Communications · doi:10.1038/s41467-019-11819-0 · Cited by 44
Ets2 suppresses inflammatory cytokines through MAPK/NF-κB signaling and directly binds to the IL-6 promoter in macrophages
Ma, X., Jiang, Z., Li, N., Jiang, W., Gao, P., Yang, M., Yu, X., Wang, G., & Zhang, Y. (2019) · Aging · doi:10.18632/aging.102480 · Cited by 44
Cutibacterium acnes Infection Induces Type I Interferon Synthesis Through the cGAS-STING Pathway
Fischer, K., Tschismarov, R., Pilz, A., Straubinger, S., Carotta, S., McDowell, A., & Decker, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.571334 · Cited by 45
Antimicrobial immunity impedes CNS vascular repair following brain injury
Mastorakos, P., Russo, M. V., Zhou, T., Johnson, K. R., & McGavern, D. B. (2021) · Nature Immunology · doi:10.1038/s41590-021-01012-1 · Cited by 44
Toll-like Receptor 9 Pathway Mediates Schlafen+-MDSC Polarization During Helicobacter-induced Gastric Metaplasias
Ding, L., Chakrabarti, J. L., Sheriff, S., Li, Q., Hong, H. N. T., Sontz, R. A., Mendoza, Z., Schreibeis, A., Helmrath, M. A., Zavros, Y. L., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.04.031 · Cited by 44
Interferon-Mediated Response to Human Metapneumovirus Infection
Uche, I. K., & Guerrero-Plata, A. (2018) · Viruses · doi:10.3390/v10090505 · Cited by 43
Regulation of the Innate Immune Response during the Human Papillomavirus Life Cycle
Moody, C. A. (2022) · Viruses · doi:10.3390/v14081797 · Cited by 47
Respiratory syncytial virus infection: an innate perspective
Johansson, C. (2016) · F1000Research · doi:10.12688/f1000research.9637.1 · Cited by 43
The Type II Secretion System of Legionella pneumophila Dampens the MyD88 and Toll-Like Receptor 2 Signaling Pathway in Infected Human Macrophages
Mallama, C. A., McCoy-Simandle, K., & Cianciotto, N. P. (2017) · Infection and Immunity · doi:10.1128/iai.00897-16 · Cited by 43
Metformin-induced suppression of IFN-α via mTORC1 signalling following seasonal vaccination is associated with impaired antibody responses in type 2 diabetes
Saenwongsa, W., Nithichanon, A., Chittaganpitch, M., Buayai, K., Kewcharoenwong, C., Thumrongwilainet, B., Butta, P., Palaga, T., Takahashi, Y., Ato, M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-60213-0 · Cited by 43
Immunogenicity mechanism of mRNA vaccines and their limitations in promoting adaptive protection against SARS-CoV-2
Salleh, M. Z., Norazmi, M. N., & Deris, Z. Z. (2022) · PeerJ · doi:10.7717/peerj.13083 · Cited by 45
Crosstalk between RNA viruses and DNA sensors: Role of the cGAS‐STING signalling pathway
Fan, Y. M., Zhang, Y. L., Luo, H., & Mohamud, Y. (2022) · Reviews in Medical Virology · doi:10.1002/rmv.2343 · Cited by 43
Staphylococcal Superantigens Spark Host-Mediated Danger Signals
Krakauer, T., Pradhan, K., & Stiles, B. G. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00023 · Cited by 48
Type I Interferons in COVID-19 Pathogenesis
Palermo, E., Carlo, D. D., Sgarbanti, M., & Hiscott, J. B. (2021) · Biology · doi:10.3390/biology10090829 · Cited by 42
Revealing the Immune Heterogeneity between Systemic Lupus Erythematosus and Rheumatoid Arthritis Based on Multi-Omics Data Analysis
Zhang, Y., & Lee, T.-Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095166 · Cited by 42
The important roles of type I interferon and interferon-inducible genes in systemic lupus erythematosus
Luo, S., Wang, Y., Zhao, M., & Lu, Q. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.10.012 · Cited by 42
A Murine Herpesvirus Closely Related to Ubiquitous Human Herpesviruses Causes T-Cell Depletion
Patel, S. J., Zhao, G., Penna, V. R., Park, E., Lauron, E. J., Harvey, I. B., Beatty, W. L., Plougastel-Douglas, B., Poursine‐Laurent, J., Fremont, D. H., et al. (2017) · Journal of Virology · doi:10.1128/jvi.02463-16 · Cited by 42
Src family kinases Fyn and Lyn are constitutively activated and mediate plasmacytoid dendritic cell responses
Dallari, S., Macal, M., Loureiro, M. E., Jo, Y., Swanson, L., Hesser, C. R., Ghosh, P., & Zúñiga, E. I. (2017) · Nature Communications · doi:10.1038/ncomms14830 · Cited by 44
IRF9 Prevents CD8 + T Cell Exhaustion in an Extrinsic Manner during Acute Lymphocytic Choriomeningitis Virus Infection
Huber, M., Suprunenko, T., Ashhurst, T. M., Marbach, F., Raifer, H., Wolff, S., Strecker, T., Viengkhou, B., Jung, S. R., Obermann, H.-L., et al. (2017) · Journal of Virology · doi:10.1128/jvi.01219-17 · Cited by 43
Transfection reagent Lipofectamine triggers type I interferon signaling activation in macrophages
Guo, X., Wang, H., Li, Y., Leng, X., Huang, W., Ma, Y., Xu, T., & Qi, X. (2018) · Immunology and Cell Biology · doi:10.1111/imcb.12194 · Cited by 43
SLAMF7 Is a Critical Negative Regulator of IFN-α–Mediated CXCL10 Production in Chronic HIV Infection
O’Connell, P., Pepelyayeva, Y., Blake, M. K., Hyslop, S., Crawford, R. B., Rizzo, M. D., Pereira‐Hicks, C., Godbehere, S., Dale, L., Gulick, P. G., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800847 · Cited by 42
heme oxygenase-1 agonist CoPP suppresses influenza virus replication through IRF3-mediated generation of IFN-α/β
Ma, L., Zhang, P., Wang, H., Li, Y., Hu, J., Jiang, J., & Li, Y. (2018) · Virology · doi:10.1016/j.virol.2018.11.016 · Cited by 43
Role of NLRs in the Regulation of Type I Interferon Signaling, Host Defense and Tolerance to Inflammation
Kienes, I., Weidl, T., Mirza, N., Chamaillard, M., & Kufer, T. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031301 · Cited by 42
Broad-Spectrum Robust Direct Bactericidal Activity of Fish IFNφ1 Reveals an Antimicrobial Peptide–like Function for Type I IFNs in Vertebrates
Xiao, X., Zhu, W., Zhang, Y., Liao, Z., Wu, C., Yang, C., Zhang, Y., Xiao, S., & Su, J. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000680 · Cited by 42
Degradation Products of Complex Arabinoxylans by Bacteroides intestinalis Enhance the Host Immune Response
Yasuma, T., Toda, M., Abdel-Hamid, A. M., D’Alessandro‐Gabazza, C. N., Kobayashi, T., Nishihama, K., D’Alessandro, V. F., Pereira, G. V., Mackie, R. I., Gabazza, E. C., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9061126 · Cited by 42
Differential Cytokine-Induced Responses of Polarized Microglia
Chauhan, P., Sheng, W. S., Hu, S., Prasad, S., & Lokensgard, J. R. (2021) · Brain Sciences · doi:10.3390/brainsci11111482 · Cited by 42
Knocking on Closed Doors: Host Interferons Dynamically Regulate Blood-Brain Barrier Function during Viral Infections of the Central Nervous System
Daniels, B. P., & Klein, R. S. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005096 · Cited by 42
Executioner caspases restrict mitochondrial RNA-driven Type I IFN induction during chemotherapy-induced apoptosis
Killarney, S. T., Washart, R., Soderquist, R. S., Hoj, J. P., Lebhar, J., Lin, K., & Wood, K. C. (2023) · Nature Communications · doi:10.1038/s41467-023-37146-z · Cited by 44
Protein phosphatase 1 abrogates IRF7‐mediated type I IFN response in antiviral immunity
Wang, L., Zhao, J., Ren, J., Hall, K. H., Moorman, J. P., Yao, Z. Q., & Ning, S. (2016) · European Journal of Immunology · doi:10.1002/eji.201646491 · Cited by 41
Differential Production of Type I IFN Determines the Reciprocal Levels of IL-10 and Proinflammatory Cytokines Produced by C57BL/6 and BALB/c Macrophages
Howes, A., Taubert, C., Blankley, S., Spink, N., Wu, X., Graham, C. M., Zhao, J., Saraiva, M., Ricciardi‐Castagnoli, P., Bancroft, G. J., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501923 · Cited by 41
Self-citation
Pathogenic mechanisms of IgE-mediated inflammation in self-destructive autoimmune responses
Ettinger, R., Karnell, J. L., Hénault, J., Panda, S. K., Riggs, J. M., Kolbeck, R., & Sanjuán, M. A. F. (2017) · Autoimmunity · doi:10.1080/08916934.2017.1280670 · Cited by 42
Pegylated Interferon-α–Induced Natural Killer Cell Activation Is Associated With Human Immunodeficiency Virus-1 DNA Decline in Antiretroviral Therapy–Treated HIV-1/Hepatitis C Virus–Coinfected Patients
Hua, S., Viganó, S., Tse, S. Y., Ouyang, Z., Harrington, S., Negron, J., García‐Broncano, P., Marchetti, G. C., Genebat, M., Leal, M., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix1111 · Cited by 41
How dendritic cells sense and respond to viral infections
Marongiu, L., Valache, M., Facchini, F. A., & Granucci, F. (2021) · Clinical Science · doi:10.1042/cs20210577 · Cited by 41
A Novel Antimicrobial Peptide Derived from Bony Fish IFN1 Exerts Potent Antimicrobial and Anti-Inflammatory Activity in Mammals
Xiao, X., Lu, H., Zhu, W., Zhang, Y., Huo, X., Yang, C., Xiao, S., Zhang, Y., & Su, J. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02013-21 · Cited by 43
Probiotic-Based Bacteriocin: Immunity Supplementation Against Viruses. An Updated Review
Umair, M., Jabbar, S., Zhaoxin, L., Zhang, J., Abid, M., Khan, K.-U.-R., Korma, S. A., Alghamdi, M. A., El‐Saadony, M. T., El-Hack, M. E. A., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.876058 · Cited by 42
Lipid droplets diversity and functions in inflammation and immune response
Pereira-Dutra, F. S., & Bozza, P. T. (2021) · Expert Review of Proteomics · doi:10.1080/14789450.2021.1995356 · Cited by 40
Respiratory syncytial virus non-structural protein 1 facilitates virus replication through miR-29a-mediated inhibition of interferon-α receptor
Zhang, Y., Yang, L., Wang, H., Zhang, G., & Sun, X. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.142 · Cited by 40
Getting “Inside” Type I IFNs: Type I IFNs in Intracellular Bacterial Infections
Snyder, D. T., Hedges, J. F., & Jutila, M. A. (2017) · Journal of Immunology Research · doi:10.1155/2017/9361802 · Cited by 43
Innate immune responses in RNA viral infection
Xu, Q., Tang, Y., & Huang, G. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0776-7 · Cited by 40
Genome instability independent of type I interferon signaling drives neuropathology caused by impaired ribonucleotide excision repair
Aditi, A., Downing, S. M., Schreiner, P. A., Kwak, Y. D., Li, Y., Shaw, T. I., Russell, H. R., & McKinnon, P. J. (2021) · Neuron · doi:10.1016/j.neuron.2021.09.040 · Cited by 42
Animal Model of Severe Fever With Thrombocytopenia Syndrome Virus Infection
Sun, J., Min, Y., Li, Y., Sun, X., Dèng, F., Wáng, H., & Ning, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.797189 · Cited by 40
Viral coinfection promotes tuberculosis immunopathogenesis by type I IFN signaling-dependent impediment of Th1 cell pulmonary influx
Kang, T. G., Kwon, K. W., Kim, K. S., Lee, I., Kim, M. J., Ha, S., & Shin, S. J. (2022) · Nature Communications · doi:10.1038/s41467-022-30914-3 · Cited by 40
Breaking down the cellular responses to type I interferon neurotoxicity in the brain
Viengkhou, B., & Hofer, M. J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1110593 · Cited by 41

Authors: McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A.
Affiliations: GlaxoSmithKline (United Kingdom) (GB)
National Institutes of Health (US)
National Institute for Medical Research (GB)
ORCID: Mayer-Barber, Katrin
Sher, Alan
Wack, Andreas
Venue: Nature Reviews Immunology
Publisher: Springer Science and Business Media LLC
Published: 2015-01-23
Volume: 15
Issue: 2
Pages: 87-103
ISSN: 1474-1733 (ISSN-L)
1474-1741
DOI: 10.1038/nri3787
PMC: PMC7162685
OpenAlex: W2091129202
Cited by: 2,780
References: 238
Citations by year: 2026: 263 · 2025: 333 · 2024: 364 · 2023: 330 · 2022: 330 · 2021: 307 · 2020: 194 · 2019: 160 · 2018: 166 · 2017: 169 · 2016: 119 · 2015: 44
FWCI: 15.67
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature reviews. Immunology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Wellcome Trust (FC001126)
Francis Crick Institute (10206, 10126)
Cancer Research UK (FC001126)
National Institutes of Health
Medical Research Council (U117597139, U117565642)
National Institute of Allergy and Infectious Diseases
FP7 Ideas: European Research Council (294682)
Topics: Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Keywords: type I interferon, innate immunity, viral infection, bacterial infection, parasitic infection, fungal infection, immunopathology, influenza virus, lymphocytic choriomeningitis virus, chronic viral infection, immunosuppression, B cell response, macrophage activation, Listeria monocytogenes, Mycobacterium tuberculosis, prostaglandin E2, interleukin-1, host defense
MeSH terms: Animals, Bacterial Infections, Communicable Diseases, Humans, Interferon Type I, Mycoses, Parasitic Diseases, Virus Diseases, Signal Transduction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Type I interferons in infectious disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks